Mylan Stock Buy Or Sell -

The consensus among Wall Street analysts is currently a . While some analysts maintain a "Buy" rating, recent price targets suggest limited immediate upside. Current Stock Price: ~$14.81 (as of April 27, 2026).

~$14.67, indicating a slight forecasted downside of roughly -1% . Target Range: High of $18.00 and a low of $10.00 . Investment Case: Buy vs. Sell Buy Case (Bullish) Sell/Hold Case (Bearish)

AI responses may include mistakes. For financial advice, consult a professional. Learn more mylan stock buy or sell

Recent FDA warnings and import alerts regarding manufacturing facilities in India (Indore and Nashik) continue to impact EBITDA estimates.

The company expects 2026 to be a "pivotal year" with 2% revenue growth and $650 million in planned cost savings. The consensus among Wall Street analysts is currently a

Technical analysis indicates a recent "sell signal" from a pivot top point reached in late April 2026. Financial Health & Outlook

To evaluate whether to "buy or sell," you must look at performance and analyst sentiment as of April 2026. Viatris (VTRS) Analyst Ratings & Price Targets (April 2026) Sell Buy Case (Bullish) Sell/Hold Case (Bearish) AI

Discounted Cash Flow (DCF) models suggest the stock is significantly undervalued, with some estimates placing "fair value" as high as $56.03 .